Back

COR-1389, a long-acting selective CRF-2 receptor agonist, in HFpEF with pulmonary hypertension due to left-heart disease: phase 1b randomised trial using wireless pulmonary artery pressure monitoring

9 May 2026 (08:30 - 09:00)
Organised by: Logo
Congress Presentation Part of: Key insights from heart failure trials Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Marcin Ufnal

Medical University of Warsaw, Warsaw (Poland)

4 More presentations in this session

Presentation thumbnail
Cardiac glycosides in heart failure with reduced ejection fraction in the era of contemporary guideline-directed medical therapy: a systematic review and meta-analysis
Doctor B. Lage Garcia (Guimaraes, PT)
Abstract Slides
Presentation thumbnail
Asymptomatic LV dysfunction in individuals with markedly increased coronary artery calcium: baseline CMR findings from EARLY-SYNERGY
Doctor T. Severijn (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Longitudinal patterns of guideline-directed medical therapy use in severe heart failure with reduced ejection fraction after hospitalization: insights from the CONNECT-HF trial
Doctor P. Rambarat (Durham, US)
Abstract Slides
Presentation thumbnail
Dysregulated myocardial water balance and adverse outcomes in heart failure with preserved ejection fraction: insights from the NETDiamond cohort CMR substudy
Doctor F. Vasques-Novoa (Porto, PT)
Abstract Slides

Access the full session

Session thumbnail
Key insights from heart failure trials

The Event

Event poster

Heart Failure 2026

9 May 2026 08:30 CET
You may be interested in
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources